Cornerstone partners with Medtronic

Cornerstone Robotics and Medtronic have struck a surgical-robotics partnership that is bigger than a simple distribution tie-up. Medtronic said on September 1 it will make an approximately $700 million strategic investment in the Hong Kong-based company and gain rights to distribute Cornerstone’s Sentire robotic surgical system in select markets outside the United States where the platform is already approved. The companies are presenting the arrangement as a way to widen access to robot-assisted surgery internationally. Medtronic said Sentire will be sold alongside its Hugo robotic-assisted surgery system, giving the company what it described as a two-platform portfolio tied to its broader surgical ecosystem. ### What exactly did the two companies agree to? (news.medtronic.com) Medtronic said the agreement combines capital and commercial rights. The company said the roughly $700 million investment comes with distribution rights for Sentire in select non-U.S. markets where the system has market approval. Cornerstone Robotics said the partnership is aimed at making high-quality robotic-assisted surgery available to more patients worldwide by pairing its technology with Medtronic’s international reach. (news.medtronic.com) Medtronic said surgeons and health systems would get “more choice and flexible solutions” across different settings and procedural needs. ### Why does Sentire matter to Medtronic’s existing robotics business? Medtronic said Sentire is meant to complement, not replace, Hugo. The company said the two systems together would form a multi-port robotic portfolio, with Hugo and Sentire offered alongside connected surgical tools and digital technologies. Matt Anderson, Medtronic’s senior vice president and president of Surgical, said the company is investing across “robotic platforms, digital tools and platform-enhancing technologies” because surgeons, health systems and markets have different needs and preferences. (prnewswire.com) That framing suggests Medtronic wants broader coverage across hospital budgets, clinical workflows and regional purchasing decisions, though the company did not disclose market-by-market rollout details. (news.medtronic.com) ### Where is Cornerstone’s system already cleared for use? Cornerstone said in May that Sentire received European Union CE mark certification under the Medical Device Regulation and certification from Singapore’s Health Sciences Authority. The company said those clearances cover minimally invasive procedures in general surgery, gynecology, thoracic surgery and urology. Cornerstone’s website also says the company is founded and headquartered in Hong Kong and lists Sentire as its flagship surgical system. (news.medtronic.com) In the same May announcement, the company said it had been conducting clinical investigation work with Portsmouth Hospitals University NHS Trust in the United Kingdom since 2025 to gather real-world data and support training and adoption. ### How large is the market the companies are chasing? Medtronic said global adoption of robot-assisted surgery remains in the single digits. (en.csrbtx.com) The company used that figure to argue that there is significant room to expand access for patients, physicians and health systems worldwide. That matters because robot-assisted surgery has been one of the most contested segments in medical devices, with manufacturers trying to add procedures, geographies and hospital customers. (en.csrbtx.com) In this case, the concrete near-term fact is narrower: Medtronic is adding a second robotic platform it can distribute outside the United States where approvals are already in place. (news.medtronic.com) ### What comes next for hospitals and clinicians? The next step is commercial rollout in those select non-U.S. markets where Sentire is already approved. Medtronic said distribution rights apply only where the system has market approval, and Cornerstone’s May 2026 regulatory update identified the European Union and Singapore as cleared markets for general surgery, gynecology, thoracic and urology use. (news.medtronic.com)